ArticleCancer immunology research2023

Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression.

Zachariah P Tritz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.